Publication | Open Access

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Hematological MalignancyMedicineChronic Myeloid LeukaemiaMixed-phenotype Acute LeukemiaHematologyClinical TrialsPharmacologyMyeloid NeoplasiaPrespecified Interim AnalysisPharmacotherapyOncologyCancer ResearchHealth Sciences